Asitri Dashboard Search Clinical Trials
The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.
Saved Searches
Choose Search
Basic Search
Targeted Search
Clinical Trials Search Results
Query: "AREA[SponsorSearch](Sage Therapeutics)"
Count: 46
Selected: 0
| NCT ID | Title |
|---|
| NCT05366751 | A Study to Evaluate the Long-term Safety and Tolerability of SAGE-324 in Participants With Essential Tremor | ||
| NCT05358821 | A Study to Evaluate the Effect of SAGE-718 on Functioning Capacity in Participants With Huntington's Disease | ||
| NCT05318937 | A Study to Evaluate the Effects of SAGE-718 in Participants With Parkinson's Disease Cognitive Impairment | ||
| NCT05173012 | Study to Evaluate SAGE-324 in Participants With Essential Tremors | ||
| NCT05107128 | A Study to Evaluate the Effect of SAGE-718 on Cognitive Function in Participants With Huntington's Disease (HD) | ||
| NCT05059600 | A Study To Assess The Safe-Use Conditions For Administration of ZULRESSO® in a Home Setting | ||
| NCT05049343 | Study of SAGE-904 Using a Ketamine Challenge to Evaluate Electrophysiology, Safety, Tolerability, and Pharmacokinetics in Healthy Participants | ||
| NCT04602624 | A Study to Evaluate the Safety and Tolerability of SAGE-718 in Participants With Mild Cognitive Impairment or Mild Dementia Due to Alzheimer's Disease (AD) | ||
| NCT04537806 | A Study of Brexanolone for Acute Respiratory Distress Syndrome (ARDS) Due to Coronavirus Disease 2019 (COVID-19) | ||
| NCT04476030 | A Comparative Study of Sage-217 Plus an Antidepressant (ADT) Versus Placebo Plus an ADT in Adults With Major Depressive Disorder | ||
| NCT04476017 | A Study to Evaluate the Safety and Tolerability of SAGE-718 in Participants With Parkinson's Disease Mild Cognitive Impairment (PD-MCI) | ||
| NCT04442503 | A Study to Evaluate the Efficacy and Safety of SAGE-217 in Participants With Severe Postpartum Depression (PPD) | ||
| NCT04442490 | A Study to Evaluate the Efficacy of Sage-217 in the Treatment of Adult Participants With Major Depressive Disorder (MDD) | ||
| NCT04305275 | A Study to Evaluate the Efficacy, Safety, and Tolerability of SAGE-324 in Participants With Essential Tremor | ||
| NCT04273191 | A Study to Evaluate Multimodal Neuroimaging Parameters in Women With Postpartum Depression Who Are Receiving ZULRESSO™ (Brexanolone) | ||
| NCT04007367 | A Study to Evaluate SAGE-217 for Prevention of Relapse in Adult Subjects With Major Depressive Disorder | ||
| NCT03924492 | Expanded Access Protocol of ZULRESSO™ (Brexanolone) Injection for Adult Patients With Postpartum Depression | ||
| NCT03864614 | A Study to Evaluate SAGE-217 in Adult Participants With Major Depressive Disorder (MDD) | ||
| NCT03844906 | A Study to Assess Electrophysiology, Safety, Tolerability, and Pharmacokinetics of Multiple Doses of SAGE-718 Using Ketamine Challenge in Healthy Subjects | ||
| NCT03787758 | A Study to Evaluate Safety, Tolerability, and Pharmacokinetics of SAGE-718 Oral Solution in Patients With Huntington's Disease - Part B | ||
| NCT03771664 | A Study to Evaluate the Safety, Tolerability, and Efficacy of SAGE-217 Compared to Placebo in Adult Subjects With Comorbid Major Depressive Disorder and Insomnia | ||
| NCT03771586 | A Study to Assess the Electrophysiology, Safety, Tolerability, and Pharmacokinetics of SAGE-718 Using a Ketamine Challenge in Healthy Subjects | ||
| NCT03770780 | A Study to Assess the Electrophysiology, Safety, Tolerability, Pharmacokinetics and Pharmacodynamics Response Using Magnetic Resonance Imaging of SAGE-718 Using a Ketamine Challenge in Healthy Subjects | ||
| NCT03692910 | A Study to Evaluate SAGE-217 in Participants With Bipolar I/II Disorder With a Current Major Depressive Episode | ||
| NCT03672175 | A Study to Evaluate the Efficacy of SAGE-217 in the Treatment of Adult Subjects With Major Depressive Disorder | ||
| NCT03665038 | A Study to Assess the Safety of Brexanolone in the Treatment of Adolescent Female Participants With Postpartum Depression (PPD) | ||
| NCT03284931 | A Study to Assess the Pharmacodynamic Effects of SAGE-217 in Healthy Adults Using an Insomnia Model | ||
| NCT03000569 | A Study to Evaluate SAGE-217 in Participants With Parkinson's Disease | ||
| NCT03000530 | A Study to Evaluate SAGE-217 in Participants With Moderate to Severe Major Depressive Disorder | ||
| NCT02978781 | A Study to Evaluate SAGE-217 in Participants With Essential Tremor | ||
| NCT02978326 | A Study to Evaluate SAGE-217 in Participants With Severe Postpartum Depression | ||
| NCT02942017 | A Study to Evaluate Safety and Efficacy of SAGE-547 in Participants With Moderate Postpartum Depression (547-PPD-202C) | ||
| NCT02942004 | A Study to Evaluate Efficacy and Safety of SAGE-547 in Participants With Severe Postpartum Depression (547-PPD-202B) | ||
| NCT02614547 | A Study to Evaluate SAGE-547 in Participants With Severe Postpartum Depression | ||
| NCT02477618 | A Study With SAGE-547 for Super-Refractory Status Epilepticus | ||
| NCT02433314 | An Open Label, Expanded Access Protocol With SAGE-547 for Super-Refractory Status Epilepticus | ||
| NCT02285504 | Evaluate SAGE-547 in Female Participants With Severe Postpartum Depression | ||
| NCT02277106 | Evaluate SAGE-547 in Participants With Essential Tremor | ||
| NCT02052739 | Study to Evaluate SAGE-547 Injection as Adjunctive Therapy for the Treatment of Super-Refractory Status Epilepticus | ||
| NCT05314153 | Effects Zulresso on Postpartum Psychosis | ||
| NCT05254405 | An Open Label Pilot Study of IV Brexanolone for the Treatment of Post-Traumatic Stress Disorder | ||
| NCT05543746 | Dynamic Neural Mechanisms of Brexanolone-induced Antidepressant Effects in Postpartum Depression | ||
| NCT05223829 | Utility of Brexanolone to Target Stress-induced Alcohol Use Among Men and Women With Posttraumatic Stress Disorder | ||
| NCT01246765 | National Pregnancy Registry for Atypical Antipsychotics | ||
| NCT04025502 | Event-Related Potential (ERP) Biomarkers in Subjects With Schizophrenia and Healthy Volunteer Subjects | ||
| NCT04928703 | Effects of Ketamine on ERP/EEG Measures in Healthy Volunteers |
